drugset / Trial / NCT00641719

A Long-term Study for the Treatment of Painful Diabetic Neuropathy

NCT00641719

Phase 3 Completed 258 enrolled Eli Lilly and Company Shionogi · collab
RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of the study is to investigate safety and efficacy of duloxetine for patients with painful diabetic neuropathy at long-term use.

Timeline

Start
2008-03
Primary completion
2010-03
Completion
2010-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Duloxetine Small molecule 40 mg Oral
Subject Duloxetine Small molecule 60 mg Oral

Indications